Just in The Lancet Oncology 👉Zr-girentuximab PET–CT is highly accurate for detecting ccRCC #kidneycancer (like PSMA-PET in prostate ca) Congrats, Brian Brian Shuch, MD et al, on these practice-impacting data. Open access👉tinyurl.com/4cwkm8u5 @morr316 OncoAlert UroToday.com

History in the making: at #ERUS24 Prof Alberto Breda performs a partial nephrectomy from Bordeaux, France on a patient nearly 10,000km away in Beijing, China.

Save the date🚨 Oct 18-20 Ospedale San Raffaele and Università Vita-Salute San Raffaele host the leading global experts in Von Hippel-Lindau disease and #renalcancer

🎉EXCITING NEWS 👇 CRUK Cambridge Centre: Urological Malignancies researchers, led by Grant Stewart and Juliet Usher-Smith, have published the world’s first prospective study of screening for #kidneycancer: the Yorkshire Kidney Screening Trial (YKST). 📖Available to read now in European Urology europeanurology.com/article/S0302-…

Just in NEJM 👉the primary results of ph3 SWOG Cancer Research Network 1011 trial (n=592)👉in pts with muscle-invasive #bladdercancer undergoing radical cystectomy👉standard lymphadenectomy is sufficient (extended lymphadenectomy did not improve survival outcomes)👇Link: tinyurl.com/bdh4z5n7

Extremely true!

Here we go: News from Europe and the EU Medicines Agency: the first HIF2 inhibitor Belzutifan (already U.S. FDA) receives POSITIVE opinion for renal cancer in 1) VHL patients, 2) refractory RCC--Both studies published NEJM with 1) led by Eric Jonasch, 2) presented by Laurence Albiges ESMO - Eur. Oncology #ESMO23

IT IS THIS TIME OF THE YEAR AGAIN! TOP 10 GU Bladder/Kidney Cancer TRIALS FOR 2024 1/ Enfortumab Vedotin (EV) + Pembrolizumab new SOC for patients with metastatic #UC. Trial #EV302 displaced 30y Platinum-based combos ⏩ PFS benefit: 12.5 vs 6.3 mo (HR= 0.45) ⏩ OS benefit:

Truly honoured to have joined the first edition of the Florence Multidisciplinary Expert Meeting on RCC. Two inspiring days of lectures, debates, and new collaborations with the top European minds in the field. Florence Multidisciplinary Expert Meeting on RCC Riccardo Campi Umberto Capitanio Alessandro Larcher Grant Stewart

sciencedirect.com/science/articl… In European Urology during KidneyCAN #KCRS24. Thank you Axel and Grant for leading the charge !

🎉Great to see out a massive team work led by Hannah Harrison and Grant Stewart In most cancers there is no evidence that intensive, long-term radiological surveillance after curative surgery improves survival or QoL. Sabrina H. Rossi Juliet Usher-Smith Benjamin Lamb Anita Balakrishnan CRUK Cambridge Centre: Urological Malignancies

Fantastic to see Raghav Varma presenting at the National Ipsen RCC day on the important National Kidney Cancer Audit by Grant Stewart et al on variations in kidney cancer care across the UK. Much work to do! CRUK Cambridge Centre: Urological Malignancies Cambridge University Hospitals NHS Kidney Cancer UK CRUK Cambridge Centre

#EAU25 Congress in Madrid is already one week away! Amazing chance to present our projects, share ideas, learn from the brightest opinion leaders and celebrate the #WillyGregoir award received by our exceptional mentor Francesco Montorsi. Ready for the next!🇺🇸 Ospedale San Raffaele Università Vita-Salute San Raffaele

Only 4 days to go! Really looking forward to the #AUA25 Amer. Urol. Assn. in Las Vegas! Ospedale San Raffaele Università Vita-Salute San Raffaele

Just wrapped up an amazing #AUA2025 in Las Vegas! Cutting-edge urology research, inspiring talks, and great networking made it unforgettable. Huge thanks to the incredible HSR team for sharing the journey! #urology #AUAAnnualMeeting Università Vita-Salute San Raffaele Ospedale San Raffaele

In papillary kidney cancer, particularly hereditary leiomyomatosis–associated cases, bevacizumab plus erlotinib showed strong antitumor activity. The likelihood of a response was higher in hereditary cases than in sporadic ones. Full study results: nej.md/44aWRDP

📘 Just published in European Urology: 🔄 The 2025 EAU Guidelines on UTUC are here! 🧬 Major updates include: • Revised risk stratification framework • New recommendations for kidney-sparing approaches in low-risk UTUC • Clarified indications for perioperative chemotherapy &

Heading back home after a few intense days at Orsi Academy to achieve the product training certification for the Hugo robotic system. Skills, technology and teamwork combined to create a unique training experience. Great time with the Medtronic team! #SurgicalInnovation #Urology

📢 Don’t miss the next European Association of Urology (EAU)inar on innovations in localized RCC! 🧬 Biomarkers, 🎯 SBRT, 🧠 molecular imaging – the future of RCC care. 🗓️ Tue, 19 Aug 2025 | 🕒 18:30 CEST 🔗 Pre-register now: uroweb.org/education-even… @Uroweb European School of Urology (EAU ESU)

🌍📈🧬 #Epidemiology of #RenalCancer: #Incidence, #Mortality, #Survival, #GeneticPredisposition, and #RiskFactors authors.elsevier.com/a/1lX0v14kpm0h… Up-to -date facts and figures together with future projections at European Urology